论文部分内容阅读
目的:探究胃乐新与奥美拉唑联合治疗胃溃疡的临床治疗效果。方法:收集2013年4月~2015年4月期间的98例胃溃疡患者相关资料,按照单双号法将其分为观察组以及对照组,每组患者49例。对照组给予奥美拉唑进行治疗,观察组采用胃乐新与奥美拉唑进行治疗。对比两组患者的治疗效果。结果:经治疗后,观察组的治疗效果明显好于对照组患者,组间以P<0.05为差异,具有统计学意义。结论:对胃溃疡患者采用胃乐新与奥美拉唑联合治疗,具有一定的安全可靠性,值得在实际治疗中推广与应用。
Objective: To explore the clinical effect of Weilexin in combination with omeprazole in the treatment of gastric ulcer. Methods: The data of 98 patients with gastric ulcer from April 2013 to April 2015 were collected and divided into observation group and control group according to the single and double number method, with 49 patients in each group. The control group was treated with omeprazole, and the observation group was treated with weilexin and omeprazole. Compare the treatment effect of two groups of patients. Results: After treatment, the treatment effect of the observation group was significantly better than that of the control group, with P <0.05 as the difference, with statistical significance. Conclusion: The combination of weilexin and omeprazole in patients with gastric ulcer has certain safety and reliability, which is worthy of promotion and application in the actual treatment.